These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20159265)

  • 1. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome.
    Loock J; Lamprecht P; Timmann C; Mrowietz U; Csernok E; Gross WL
    J Allergy Clin Immunol; 2010 Feb; 125(2):500-2. PubMed ID: 20159265
    [No Abstract]   [Full Text] [Related]  

  • 2. The Schnitzler syndrome.
    Lipsker D
    Orphanet J Rare Dis; 2010 Dec; 5():38. PubMed ID: 21143856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 4. Schnitzler syndrome in a patient with a family history of monoclonal gammopathy.
    Wilmas K; Aria A; Torres-Cabala CA; Lu H; Duvic M
    Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?
    Verma D; Lerm M; Blomgran Julinder R; Eriksson P; Söderkvist P; Särndahl E
    Arthritis Rheum; 2008 Mar; 58(3):888-94. PubMed ID: 18311798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.
    Rowczenio DM; Pathak S; Arostegui JI; Mensa-Vilaro A; Omoyinmi E; Brogan P; Lipsker D; Scambler T; Owen R; Trojer H; Baginska A; Gillmore JD; Wechalekar AD; Lane T; Williams R; Youngstein T; Hawkins PN; Savic S; Lachmann HJ
    Blood; 2018 Mar; 131(9):974-981. PubMed ID: 29284595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
    Benítez Gutiérrez L; Mellor Pita S; Tutor de Ureta P; Yebra Bango M
    Med Clin (Barc); 2013 May; 140(9):427-8. PubMed ID: 23177777
    [No Abstract]   [Full Text] [Related]  

  • 8. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
    Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
    Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
    de Koning HD; Schalkwijk J; van der Meer JW; Simon A
    J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
    Ryan JG; de Koning HD; Beck LA; Booty MG; Kastner DL; Simon A
    J Allergy Clin Immunol; 2008 Jan; 121(1):260-2. PubMed ID: 17936890
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome.
    de Koning HD; van Gijn ME; Stoffels M; Jongekrijg J; Zeeuwen PL; Elferink MG; Nijman IJ; Jansen PA; Neveling K; van der Meer JW; Schalkwijk J; Simon A
    J Allergy Clin Immunol; 2015 Feb; 135(2):561-4. PubMed ID: 25239704
    [No Abstract]   [Full Text] [Related]  

  • 12. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful anakinra therapy in 2 patients with Schnitzler syndrome.
    Szturz P; Adam Z; Hájek R; Mayer J
    Onkologie; 2011; 34(5):265-8. PubMed ID: 21577034
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 15. Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra.
    Kaipiainen-Seppänen O; Punnonen K; van Gijn ME; Mononen T
    Scand J Rheumatol; 2008; 37(1):75-6. PubMed ID: 18189199
    [No Abstract]   [Full Text] [Related]  

  • 16. Anakinra for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schnitzler syndrome: A dramatic improvement with anakinra].
    Billey T; Beldjerd M; Popa L; Lassoued S
    Presse Med; 2010 Dec; 39(12):1338-9. PubMed ID: 20832239
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission of Schnitzler syndrome after treatment with anakinra.
    Frischmeyer-Guerrerio PA; Rachamalla R; Saini SS
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):617-9. PubMed ID: 18592830
    [No Abstract]   [Full Text] [Related]  

  • 19. Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra.
    Gerard S; le Goff B; Maugars Y; Berthelot JM; Malard O
    Joint Bone Spine; 2007 Dec; 74(6):659. PubMed ID: 17892965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
    Adam Z; Krejcí M; Pour L; Hájek R
    Vnitr Lek; 2009 Dec; 55(12):1196-7. PubMed ID: 20070037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.